245 related articles for article (PubMed ID: 12519314)
1. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.
Holt RI; Simpson HL; Sönksen PH
Diabet Med; 2003 Jan; 20(1):3-15. PubMed ID: 12519314
[TBL] [Abstract][Full Text] [Related]
2. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
Yuen KC; Dunger DB
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
[TBL] [Abstract][Full Text] [Related]
3. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
[TBL] [Abstract][Full Text] [Related]
4. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
Ismail IS; Miell JP; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
6. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
Hanaire-Broutin H; Sallerin-Caute B; Poncet MF; Tauber M; Bastide R; Rosenfeld R; Tauber JP
Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?
Orskov H
Metabolism; 1996 Aug; 45(8 Suppl 1):91-5. PubMed ID: 8769394
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
[TBL] [Abstract][Full Text] [Related]
9. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
11. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
Mauras N; Merimee T; Rogol AD
Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
Donahue LR; Beamer WG
J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
15. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
Yuen KC; Dunger DB
Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
[TBL] [Abstract][Full Text] [Related]
17. The role of growth hormone in diabetes mellitus.
Holly JM; Amiel SA; Sandhu RR; Rees LH; Wass JA
J Endocrinol; 1988 Sep; 118(3):353-64. PubMed ID: 3053958
[TBL] [Abstract][Full Text] [Related]
18. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
Bereket A; Lang CH; Wilson TA
Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
[TBL] [Abstract][Full Text] [Related]
20. Effect of thyroxine administration on the IGF/IGF binding protein system in neonatal and adult thyroidectomized rats.
Ramos S; Goya L; Alvarez C; Martín MA; Pascual-Leone AM
J Endocrinol; 2001 Apr; 169(1):111-22. PubMed ID: 11250652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
